Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Cash & Equivalents (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Cash & Equivalents for 16 consecutive years, with $28.2 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 10.29% to $28.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.2 million through Dec 2025, up 10.29% year-over-year, with the annual reading at $28.2 million for FY2025, 10.29% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $28.2 million at Lemaitre Vascular, up from $25.5 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $28.2 million in Q4 2025, with the low at $13.9 million in Q4 2021.
  • Average Cash & Equivalents over 5 years is $21.4 million, with a median of $21.3 million recorded in 2021.
  • Peak annual rise in Cash & Equivalents hit 114.96% in 2021, while the deepest fall reached 48.23% in 2021.
  • Over 5 years, Cash & Equivalents stood at $13.9 million in 2021, then soared by 38.1% to $19.1 million in 2022, then increased by 26.84% to $24.3 million in 2023, then rose by 5.53% to $25.6 million in 2024, then grew by 10.29% to $28.2 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $28.2 million, $25.5 million, and $27.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.